TipRanks
Aukett Swanke Group Plc (GB:BUC)
LSE:BUC
UK Market
Want to see GB:BUC full AI Analyst Report?

Aukett Swanke (BUC) AI Stock Analysis

2 Followers

Top Page

GB:BUC

Aukett Swanke

(LSE:BUC)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - Gpt-5.6Sol)
Rating:42Neutral
Price Target:
1.50 p
▼(-21.05% Downside)
Action:Reiterated
Date:10/01/26
Overall score reflects a mixed financial turnaround profile with still-weak cash generation and meaningful leverage as the primary constraints, reinforced by bearish technical momentum (below key moving averages with negative MACD). Valuation provides limited support given the negative P/E and no stated dividend yield.
Positive Factors
Revenue trajectory
Revenue has risen from 2022 through 2025, with particularly strong year-over-year growth in 2025. That trajectory indicates improving demand and scale for the professional-services platform, supporting a larger project base and potentially better operating leverage if execution remains consistent.
Negative Factors
Fragile profitability
Profitability remains fragile because 2025 results were only near break-even after a clear loss in 2024. Volatile gross margins and modest EBITDA profitability suggest earnings depend heavily on project mix and cost control, limiting confidence in sustainable returns.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue trajectory
Revenue has risen from 2022 through 2025, with particularly strong year-over-year growth in 2025. That trajectory indicates improving demand and scale for the professional-services platform, supporting a larger project base and potentially better operating leverage if execution remains consistent.
Read all positive factors

Aukett Swanke (BUC) vs. iShares MSCI United Kingdom ETF (EWC)

Aukett Swanke Business Overview & Revenue Model

Company Description
Built Cybernetics plc, headquartered in London and established in 1906, operates across the United Kingdom and Turkey, offering a diverse array of integrated professional design services through its various subsidiaries. Formerly known as Aukett S...
How the Company Makes Money
Aukett Swanke primarily makes money by charging professional fees for delivering architecture and design/consultancy services to clients on building and development projects. Revenue is typically earned through client engagements that can be struc...

Aukett Swanke Financial Statement Overview

Summary
Financials remain mixed: revenue is improving into 2025, but profitability is still near break-even with volatile margins. Leverage is meaningful (debt roughly 1.0–1.5x equity), and free cash flow has been negative in 2024–2025 despite positive operating cash flow, indicating inconsistent cash conversion.
Income Statement
46
Neutral
Balance Sheet
45
Neutral
Cash Flow
38
Negative
BreakdownTTMSep 2025Sep 2024Sep 2023Sep 2022Mar 2022
Income Statement
Total Revenue19.56M20.06M19.72M14.34M8.64M9.19M
Gross Profit2.65M3.11M14.25M1.12M862.00K652.00K
EBITDA329.00K649.00K-641.00K382.00K-120.00K-454.00K
Net Income-507.00K-31.00K-1.71M92.00K-2.28M-1.12M
Balance Sheet
Total Assets10.89M12.19M13.46M14.90M8.19M11.90M
Cash, Cash Equivalents and Short-Term Investments189.00K536.00K755.00K811.00K28.00K515.00K
Total Debt3.10M3.25M2.41M4.93M3.07M3.39M
Total Liabilities8.89M9.61M11.06M11.53M7.79M8.84M
Stockholders Equity2.00M2.58M2.39M3.37M401.00K3.07M
Cash Flow
Free Cash Flow3.00K-472.00K-301.00K1.22M-932.00K-142.00K
Operating Cash Flow115.00K114.00K89.00K1.38M-884.00K-109.00K
Investing Cash Flow-781.00K-334.00K2.21M508.00K1.02M-140.00K
Financing Cash Flow860.00K470.00K-2.54M-1.12M-648.00K-201.00K

Aukett Swanke Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1.90
Price Trends
50DMA
1.72
Negative
100DMA
1.63
Positive
200DMA
1.85
Negative
Market Momentum
MACD
-0.03
Positive
RSI
29.52
Positive
STOCH
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:BUC, the sentiment is Negative. The current price of 1.9 is above the 20-day moving average (MA) of 1.80, above the 50-day MA of 1.72, and above the 200-day MA of 1.85, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:BUC.

Aukett Swanke Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
£87.65M11.6816.97%6.33%-5.55%-22.10%
68
Neutral
£140.93M24.295.51%4.85%10.68%-25.87%
68
Neutral
£539.63M13.9120.94%7.06%-3.52%-10.90%
65
Neutral
£736.06M20.555.19%4.57%4.33%-30.43%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
54
Neutral
£267.26M861.760.15%3.86%6.87%-91.28%
42
Neutral
£6.58M-11.79-22.11%4.11%-5.30%―
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:BUC
Aukett Swanke
1.65
-0.30
-15.38%
GB:ALU
Alumasc
238.50
-88.83
-27.14%
GB:ECEL
Eurocell
142.50
21.50
17.77%
GB:JHD
James Halstead
125.00
-11.60
-8.49%
GB:NXR
Norcros
295.00
35.03
13.47%
GB:GEN
Genuit Group
283.80
-68.21
-19.38%

Aukett Swanke Corporate Events

Business Operations and StrategyDelistings and Listing ChangesM&A TransactionsPrivate Placements and Financing
Built Cybernetics moves to acquire AI energy specialist Ecolibrium and launch equity raise
Positive
Sep 28, 2026
Built Cybernetics plans to acquire Ecolibrium, Inc entirely through the issue of new shares and to raise additional equity capital, creating an enlarged smart building technology group with expanded proprietary software, a broader international in...
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Built Cybernetics Partly Sells Frankfurt Stake to Fund Smart Buildings Push
Positive
Sep 11, 2026
Built Cybernetics plc has agreed to sell half of its 50% stake in Aukett + Heese Frankfurt GmbH to long-standing partner Lutz Heese for €250,000, aligning the joint venture’s ownership structure with that of the larger Berlin practice....
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 01, 2026